Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Another hint at Anatabine Citrate?

New Drug for Severe Form of Arthritis Shows Promise in Trial in Drugs.com, Dec. 23, 2015

Excerpts:
"A drug recently approved for the skin condition psoriasis may also help people with a debilitating form of arthritis that attacks the spine, a new clinical trial finds."

"Almost 3 million Americans have ankylosing spondylitis, according to the U.S. Centers for Disease Control and Prevention. The disease is usually diagnosed in young people, before the age of 40.

The exact cause is unknown, but spondylitis does involve abnormal immune system activity that triggers chronic inflammation in the spine. A few gene variants have been linked to an increased risk of the disease -- and it's thought that some mix of genes and environment is to blame, according to the Spondylitis Association of America."

"Zashin saw the results as encouraging for spondylitis patients who are not getting relief from current treatments. "There is an entirely new class of drugs on the horizon that might be of benefit for them," he said."

Article at:
http://www.drugs.com/news/new-severe-arthritis-shows-promise-trial-59517.html?utm_source=ddc&utm_medium=email&utm_campaign=Weekly+Drug+News+Round-Up%3A+December+23%2C+2015&utm_content=New+Drug+for+Severe+Form+of+Arthritis+Shows+Promise+in+Trial